The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-[2-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]diazepin-3-yl)-ethyl]-naphthalene-2-carboxylic acid methyl ester ID: ALA157951
PubChem CID: 10713804
Max Phase: Preclinical
Molecular Formula: C20H20N4O3
Molecular Weight: 364.41
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COC(=O)c1cc(CCn2cnc3c2NC=NCC3O)c2ccccc2c1
Standard InChI: InChI=1S/C20H20N4O3/c1-27-20(26)15-8-13-4-2-3-5-16(13)14(9-15)6-7-24-12-23-18-17(25)10-21-11-22-19(18)24/h2-5,8-9,11-12,17,25H,6-7,10H2,1H3,(H,21,22)
Standard InChI Key: SULFMPMRSCCZRA-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
3.0917 -1.3417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5292 -1.7542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3375 -0.7917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0625 -1.4500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4917 -2.3417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9292 -0.8542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6667 -1.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6292 -1.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2042 -1.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5000 -1.4375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1500 -1.4625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6667 -2.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0042 -2.6917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1417 -2.6667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6292 -2.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4167 -2.5167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5875 -1.7625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1042 -1.4542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2167 -0.8667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.7250 -1.7875 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1542 -0.9292 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.2125 -1.9625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1375 -3.2750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1000 -2.6667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7167 -2.3917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6167 -3.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1000 -3.2667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 1 1 0
4 2 1 0
5 2 1 0
6 3 2 0
7 11 2 0
8 18 1 0
9 7 1 0
10 1 1 0
11 8 1 0
12 14 2 0
13 5 1 0
14 15 1 0
15 8 2 0
16 22 1 0
17 4 1 0
18 17 1 0
19 9 2 0
20 9 1 0
21 10 1 0
22 10 1 0
23 14 1 0
24 15 1 0
25 20 1 0
26 27 1 0
27 24 2 0
6 4 1 0
13 16 2 0
12 7 1 0
23 26 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 364.41Molecular Weight (Monoisotopic): 364.1535AlogP: 2.55#Rotatable Bonds: 4Polar Surface Area: 88.74Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.06CX Basic pKa: 6.50CX LogP: 1.95CX LogD: 1.90Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.69Np Likeness Score: -0.23
References 1. Kasibhatla SR, Bookser BC, Xiao W, Erion MD.. (2001) AMP deaminase inhibitors. 5. Design, synthesis, and SAR of a highly potent inhibitor series., 44 (4): [PMID:11170651 ] [10.1021/jm000355t ]